RNAi triggers (Arrowhead Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRNAi triggers (Arrowhead Pharmaceuticals)
Drug Alias NameAD-02001AD-02619
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionApolipoprotein A-I inhibitorsRNA interference
TargetsApolipoprotein A-I
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrowhead Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A